Difficulty: Medium
Average Score: 76%
Practice
Which of the following is a non-steroidal antiandrogen that has been found to be palliative in advanced carcinoma prostate?
Correct answer
D
Rationale
The correct answer is D) Flutamide. Flutamide is a non-steroidal antiandrogen commonly used in the treatment of advanced carcinoma prostate. It works by blocking the action of androgens (male hormones) in the body, which can slow the growth of prostate cancer cells. Flutamide is often used in combination with other medications or therapies to provide palliative care and improve quality of life in patients with advanced prostate cancer.
A) Cyproterone acetate is also an antiandrogen but is more commonly used in the treatment of conditions like hirsutism and acne, rather than prostate cancer.
B) Danazol is a synthetic steroid derivative with antiandrogenic properties, mainly used in the treatment of endometriosis and fibrocystic breast disease, not prostate cancer.
C) Finasteride is a 5-alpha-reductase inhibitor used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness. It does not have the same antiandrogenic effects as flutamide in advanced carcinoma prostate.
In an educational context, understanding the mechanisms of action and specific uses of antiandrogens like flutamide is crucial for healthcare providers involved in the care of patients with prostate cancer. Knowing the appropriate medications for palliative care in advanced carcinoma prostate can help in providing effective symptom management and improving patient outcomes.
A) Cyproterone acetate is also an antiandrogen but is more commonly used in the treatment of conditions like hirsutism and acne, rather than prostate cancer.
B) Danazol is a synthetic steroid derivative with antiandrogenic properties, mainly used in the treatment of endometriosis and fibrocystic breast disease, not prostate cancer.
C) Finasteride is a 5-alpha-reductase inhibitor used in the treatment of benign prostatic hyperplasia (BPH) and male pattern baldness. It does not have the same antiandrogenic effects as flutamide in advanced carcinoma prostate.
In an educational context, understanding the mechanisms of action and specific uses of antiandrogens like flutamide is crucial for healthcare providers involved in the care of patients with prostate cancer. Knowing the appropriate medications for palliative care in advanced carcinoma prostate can help in providing effective symptom management and improving patient outcomes.